Franklin Street Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,400	Closed	-$228K	–	134
2020 Q1	$228K	Hold	5,400	–	–	0.03%	120
2019 Q4	$231K	Buy	+5,400	New	+$231K	0.03%	138
2017 Q4	–	Sell	-5,400	Closed	-$203K	–	167
2017 Q3	$203K	Buy	+5,400	New	+$203K	0.03%	145